Wilfred Ngwa, Beatrice W Addai, Isaac Adewole, Victoria Ainsworth, James Alaro, Olusegun I Alatise, Zipporah Ali, Benjamin O Anderson, Rose Anorlu, Stephen Avery, Prebo Barango, Noella Bih, Christopher M Booth,

Olayide AgodirinID1,2*, Samuel Olatoke1, Ganiyu Rahman1,3, Oladapo Kolawole4,Saliu Oguntola5, Olalekan Olasehinde6, Omobolaji Ayandipo7, Julius Olaogun8,Aba Katung9, Amarachukwu Etonyeaku10, Olufemi Habeeb1, Ademola Adeyeye11,John AgboolaID2, Halimat Akande12, Olusola Akanbi5, Oluwafemi Fatudimu13,Anthony Ajiboye2

Although the incidence of colorectal cancer is believed to be rising in sub-Saharan Africa, the true values are largely unknown, with current figures extrapolated from descriptive studies done in a

Olusegun I Alatise, Anna J Dare, Patrick A Akinyemi, Fatimah B Abdulkareem, Samuel A Olatoke,Gregory C Knapp,T Peter Kingham, for the African Research for Oncology Colorectal Screening and Early Detection

IA Owoade1, F Wuraola1,2, O Olasehinde1,2, PA Akinyemi1, K Randolph1,3, AJ Dare1,3, TP Kingham1,3, OI Alatise1,

Breast cancer is the most prevalent cancer and leading cause of cancer-related deaths in women worldwide.1 In high-income countries with robust health-care systems and population screening programmes, most breast cancer

Victoria L Mango, Olalekan Olasehinde, Adeleye D Omisore, Funmilola O Wuraola, Olusola C Famurewa, Varadan Sevilimedu, Gregory C Knapp, Evan Steinberg, Promise R Akinmaye, Boluwatife D Adewoyin, Anya Romanoff, Philip

Sharma, Avinash ; Alatise, Olusegun Isaac ; O’Connell, Kelli ; Ogunleye, Samson Gbenga ; Aderounmu, Adewale Abdulwasiu ; Samson, Marquerite L ; Wuraola, Funmilola ; Olasehinde, Olalekan ; Kingham, T

Alatise, Olusegun I ; Knapp, Gregory C ; Bebington, Brendan ; Ayodeji, Patrick ; Dare, Anna ; Constable, Jeremy ; Olasehinde, Olalekan ; Kingham, T. Peter World journal of surgery,

The fecal immunochemical test (FIT) for hemoglobin is recommended for colorectal cancer (CRC) screening in resource-limited environments. However, there are several unique variables that may alter FIT performance in this setting, including endemic intestinal parasites and high ambient temperature. This prospective study evaluated the performance of FIT in asymptomatic, average-risk individuals of screening age in rural Nigeria.

To address the increasing burden of cancer in Nigeria, the National Cancer Control Plan outlines the development of 8 public comprehensive cancer centers. We map population-level geospatial access to these eight centers and explore equity of access and the impact of future development.

Cancer is rapidly becoming a public health crisis in low-income and middle-income countries. In sub-Saharan Africa, patients often present with advanced disease. Little health-care infrastructure exists, and few personnel are available for the care of patients.

70% of the 24 million people predicted to have cancer by 2050 will live in low- and middle-income countries (LMIC). As a result, cancer care is becoming a priority for healthcare systems in West Africa.

Breast cancer incidence may be increasing in low‐ and middle‐income countries (LMIC). This study estimates the prevalence of breast masses in Rwanda (RW) and Sierra Leone (SL) and identifies barriers to care for women with breast masses only.

This study aimed to describe the characteristics of patients diagnosed with hepatocellular carcinoma (HCC) at the Komfo Anokye Teaching Hospital (KATH) in Ghana and to determine their treatment options per the Barcelona Clinic Liver Cancer (BCLC) algorithm.

Both infectious and noninfectious related malignancies are a growing problem in low- and middle-income countries (LMIC). It is difficult to extrapolate data and guidelines regarding cancer care from high-income countries (HIC) to cancer patients in LMIC. Due to the rise in noncommunicable cancer rates,

Cancer care is quickly becoming a key component of global public health efforts. At the same time, the cancer incidence rate in low- and middle-income countries (LMIC) continues to increase dramatically. Only 15 % of cancers reported in 1970 were in LMIC, but 70 % is the proportion predicted by 2030

Surgery is essential for global cancer care in all resource settings. Of the 15·2 million new cases of cancer in 2015, over 80% of cases will need surgery, some several times. By 2030, we estimate that annually 45 million surgical procedures will be needed worldwide.

Noncommunicable diseases are now recognized by the United Nations and WHO as a major public health crisis. Cancer is a main part of this problem, and health care systems are facing a great challenge to improve cancer care, control costs, and increase systems efficiency.

Hepatocellular carcinoma (HCC) is highly endemic in Africa (1). There is a general anecdotal consensus that persons with HCC induced by viral hepatitis or other causes in Africa present at younger ages than in other regions of the World.

There is an increasing effort in the global public health community to strengthen research capacity in low- and middle-income countries, but there is no consensus on how best to approach such endeavors. Successful consortia that perform research on HIV/AIDS and other infectious diseases exist, but few papers have been published detailing the challenges faced and lessons learned in setting up and running a successful research consortium.

The UN High Level Meeting on the Prevention and Control of Non-Communicable Diseases (NCDs) held in 2011 drew attention to the global burden of NCDs, including cancer. While there was no specific mention of surgery in general or cancer surgery in particular, this high level discussion brought to attention the burden of cancer and garnered international agreement to launch cancer control efforts.

In low- and middle-income countries like Nigeria, women present with advanced breast cancer at an earlier age. Given the limited resources, development of screening programs that parallel resource capabilities of low- and middle-income countries is imperative.

Colorectal cancer (CRC) rates in low-resource countries, which typically lack CRC screening programs, are rising. This study determined whether a risk model for patients with rectal bleeding could identify patients with curable CRC.

Purpose Colorectal cancer (CRC) incidence rates are steadily increasing in Nigeria. Organized screening is still largely unused because of financial and logistical barriers; most CRCs are detected by symptoms. One symptom of CRC is rectal bleeding.

Early postmastectomy discharge with a drain in place is standard practice in most developed countries. Its feasibility has not been evaluated in low resource settings like Nigeria.

The global burden of colorectal cancer (CRC) will continue to increase for the foreseeable future, largely driven by increasing incidence and mortality in low- and middle-income countries (LMICs) such as Nigeria.

The majority of women managed for breast cancer in Nigeria are relatively young, many in their forties. Mastectomy, the most common surgical treatment, raises psychosocial concerns. Understanding these concerns may help address the fears of women who refuse treatment and aid in the care of those who have had mastectomy.

Cancer incidence is increasing in sub-Saharan Africa, yet there is little information on the capacity of pathology laboratories in this region. We aimed to assess the current state of pathology services in Nigeria to guide strategies to ensure best practices and improve the quality of surgical specimen handling.

The fecal immunochemical test (FIT) for hemoglobin is recommended for colorectal cancer (CRC) screening in resource-limited environments. However, there are several unique variables that may alter FIT performance in this setting, including endemic intestinal parasites and high ambient temperature. This prospective study evaluated the performance of FIT in asymptomatic, average-risk individuals of screening age in rural Nigeria.

To address the increasing burden of cancer in Nigeria, the National Cancer Control Plan outlines the development of 8 public comprehensive cancer centers. We map population-level geospatial access to these eight centers and explore equity of access and the impact of future development.